Filing metadata

Accession number
0001179110-21-004705
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Apr 29, 2021
Reporting period
Apr 27, 2021
Description
Insider transaction

Explore SEC Filings Hub